JAC Advance Access originally published online on January 12, 2008
Journal of Antimicrobial Chemotherapy 2008 61(3):762; doi:10.1093/jac/dkm530
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Erratum |
Resistance of the antibacterial agent ceragenin CSA-13 to inactivation by DNA or F-actin and its activity in cystic fibrosis sputum
J Antimicrob Chemother 2007; 60: 535–45
The Transparency declaration in this manuscript was inaccurate. The corrected declaration is below. The authors apologize for this omission.
P. B. Savage serves as a consultant for Ceragenix Pharmaceuticals. Ceragenins have been licensed by Brigham Young University to Ceragenix Pharmaceuticals.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||